WO2009014127A1 - 自己抗体の産生に関連する疾患の予防又は治療のための組成物 - Google Patents
自己抗体の産生に関連する疾患の予防又は治療のための組成物 Download PDFInfo
- Publication number
- WO2009014127A1 WO2009014127A1 PCT/JP2008/063145 JP2008063145W WO2009014127A1 WO 2009014127 A1 WO2009014127 A1 WO 2009014127A1 JP 2008063145 W JP2008063145 W JP 2008063145W WO 2009014127 A1 WO2009014127 A1 WO 2009014127A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- autoantibody
- prevention
- treatment
- composition
- production
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
- A61K35/64—Insects, e.g. bees, wasps or fleas
- A61K35/644—Beeswax; Propolis; Royal jelly; Honey
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/52—Adding ingredients
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L21/00—Marmalades, jams, jellies or the like; Products from apiculture; Preparation or treatment thereof
- A23L21/20—Products from apiculture, e.g. royal jelly or pollen; Substitutes therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Immunology (AREA)
- Diabetes (AREA)
- Insects & Arthropods (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Nutrition Science (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Endocrinology (AREA)
- Neurology (AREA)
- Physical Education & Sports Medicine (AREA)
- Zoology (AREA)
- Animal Husbandry (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- Dermatology (AREA)
- Rheumatology (AREA)
- Reproductive Health (AREA)
- Emergency Medicine (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Biomedical Technology (AREA)
- Gynecology & Obstetrics (AREA)
- Obesity (AREA)
Abstract
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN200880022123A CN101795698A (zh) | 2007-07-24 | 2008-07-23 | 用于预防或治疗与自身抗体产生相关的疾病的组合物 |
JP2009524491A JP5225277B2 (ja) | 2007-07-24 | 2008-07-23 | 自己抗体の産生に関連する疾患の予防又は治療のための組成物 |
US12/670,244 US20100209527A1 (en) | 2007-07-24 | 2008-07-23 | Composition for prevention or treatment of disease associated with production of autoantibody |
US14/040,002 US20140030353A1 (en) | 2007-07-24 | 2013-09-27 | Composition for prevention or treatment of disease associated with production of autoantibody |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2007192148 | 2007-07-24 | ||
JP2007-192148 | 2007-07-24 |
Related Child Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US12/670,244 A-371-Of-International US20100209527A1 (en) | 2007-07-24 | 2008-07-23 | Composition for prevention or treatment of disease associated with production of autoantibody |
US14/040,002 Division US20140030353A1 (en) | 2007-07-24 | 2013-09-27 | Composition for prevention or treatment of disease associated with production of autoantibody |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2009014127A1 true WO2009014127A1 (ja) | 2009-01-29 |
Family
ID=40281378
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2008/063145 WO2009014127A1 (ja) | 2007-07-24 | 2008-07-23 | 自己抗体の産生に関連する疾患の予防又は治療のための組成物 |
Country Status (4)
Country | Link |
---|---|
US (2) | US20100209527A1 (ja) |
JP (1) | JP5225277B2 (ja) |
CN (1) | CN101795698A (ja) |
WO (1) | WO2009014127A1 (ja) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9364507B2 (en) * | 2009-08-11 | 2016-06-14 | Imagilin Technology, Llc | Probiotic enhancement of steroid and immune suppressor activity in mammals with chronic diseases |
KR101293645B1 (ko) * | 2011-02-15 | 2013-08-07 | 조신영 | 신장염 예방 또는 치료용 약학 조성물 |
MA35677B1 (fr) * | 2013-01-28 | 2014-12-01 | Univ Moulay Ismail | Produit a base d'une preparation naturelle contre l'anemie |
US10308408B2 (en) * | 2014-05-15 | 2019-06-04 | Nichiban Co., Ltd. | Packaging for adhesive patch containing rivastigmine |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH09100236A (ja) * | 1995-10-04 | 1997-04-15 | Pola Chem Ind Inc | 抗体産生抑制剤及び肌柔軟化剤を含有してなる浴用剤 |
WO2004019971A1 (ja) * | 2002-08-29 | 2004-03-11 | Hayashibara, Ken | 抗アレルギー剤 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AUPP784398A0 (en) * | 1998-12-21 | 1999-01-21 | Monash University | Kidney disease detection and treatment |
JP5384777B2 (ja) * | 2001-12-18 | 2014-01-08 | 有限会社大長企画 | 強筋肉剤、抗炎症剤 |
JP5144000B2 (ja) * | 2004-08-25 | 2013-02-13 | 太陽化学株式会社 | 形質転換増殖因子β抑制用組成物 |
-
2008
- 2008-07-23 JP JP2009524491A patent/JP5225277B2/ja not_active Expired - Fee Related
- 2008-07-23 US US12/670,244 patent/US20100209527A1/en not_active Abandoned
- 2008-07-23 CN CN200880022123A patent/CN101795698A/zh active Pending
- 2008-07-23 WO PCT/JP2008/063145 patent/WO2009014127A1/ja active Application Filing
-
2013
- 2013-09-27 US US14/040,002 patent/US20140030353A1/en not_active Abandoned
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH09100236A (ja) * | 1995-10-04 | 1997-04-15 | Pola Chem Ind Inc | 抗体産生抑制剤及び肌柔軟化剤を含有してなる浴用剤 |
WO2004019971A1 (ja) * | 2002-08-29 | 2004-03-11 | Hayashibara, Ken | 抗アレルギー剤 |
Non-Patent Citations (4)
Title |
---|
"iwanami Seibutsugaku Jiten, 4th edetion", 21 March 1996, pages: 561 * |
EREM C. ET AL.: "The effects of royal jelly on autoimmunity in Graves disease", ENDOCRINE, vol. 30, no. 2, 2006, pages 175 - 183 * |
IGAKU-SHOIN LTD.: "Igaku Daijiten, 1st edetion", 1 March 2003, article "Zenshin Erythematous", pages: 1435 * |
KONDO M.: "Watashi no Hachimitsu Kenkoho -Nanbyo o Kokufuku shita Taiken kara", HONEYBEE SCIENCE, vol. 11, no. 2, 10 April 1990 (1990-04-10), pages 85 - 88 * |
Also Published As
Publication number | Publication date |
---|---|
JP5225277B2 (ja) | 2013-07-03 |
CN101795698A (zh) | 2010-08-04 |
US20140030353A1 (en) | 2014-01-30 |
US20100209527A1 (en) | 2010-08-19 |
JPWO2009014127A1 (ja) | 2010-10-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2008070268A3 (en) | Pharmaceutical compositions | |
WO2007104789A3 (en) | Amylin derivatives | |
WO2009051670A3 (en) | Oxylipin compounds for the treatment of ophthalmic conditions | |
WO2007133802A3 (en) | Pharmaceutical formulations of pimavanserin | |
WO2006096518A3 (en) | Improved gacyclidine formulations | |
WO2007093627A3 (de) | Biozide zusammensetzung | |
WO2009129246A3 (en) | Compositions and methods for preparing and using same | |
WO2010049454A3 (en) | Antimicrobial composition from copepods | |
WO2008067219A3 (en) | Quinazolinone modulators of tgr5 | |
WO2009014650A3 (en) | Recombinant vibrio cholerae exotoxins | |
WO2008066784A3 (en) | Expression of foxp3 by cancer cells | |
AP2011005978A0 (en) | 2, 4 diaminopyrimidines for the treatment of diseases characterised by excessive or abnormal cell proliferation. | |
WO2009111633A3 (en) | Mercaptan and seleno-mercaptan compounds and methods of using them | |
WO2011009938A3 (en) | Stambomycin and derivatives, their production and their use as drugs | |
WO2008129501A3 (en) | Pharmaceutical compositions of duloxetine | |
WO2011147951A8 (en) | Cycloamino derivatives as gpr119 agonists | |
WO2009074247A8 (de) | Neue 2-aryl-thiazol-4-carbonsäureamid-derivate, deren herstellung und verwendung als arzneimittel | |
WO2011090694A8 (en) | Orally administrable film dosage forms containing ondansetron | |
WO2009124962A3 (en) | Sulfonamides | |
WO2008135819A8 (en) | Hydrochloride salt of 5-[3-(3-hydroxyphenoxy)azetidin-1-yl]-5-methyl-2,2- diphenylhexanamide | |
WO2008111096A3 (en) | Novel prodrugs | |
WO2007131907A3 (en) | 1h-indol-5-yl-piperazin-1-yl-methanone derivatives | |
WO2009144551A3 (en) | Use of dronedarone or a pharmaceutically acceptable salt thereof, for the preparation of a medicament for regulating the potassium level in the blood | |
WO2008075205A3 (en) | Improved process for the preparation of voriconazole | |
WO2008023264A3 (en) | Coenzyme q10 production from marine bacteria |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 200880022123.8 Country of ref document: CN |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 08791426 Country of ref document: EP Kind code of ref document: A1 |
|
ENP | Entry into the national phase |
Ref document number: 2009524491 Country of ref document: JP Kind code of ref document: A |
|
WWE | Wipo information: entry into national phase |
Ref document number: 12670244 Country of ref document: US |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 08791426 Country of ref document: EP Kind code of ref document: A1 |